109 related articles for article (PubMed ID: 7350611)
1. Improved detectability of VX2 carcinoma in the rabbit liver with contrast enhancement in computed tomography.
Violante MR; Dean PB
Radiology; 1980 Jan; 134(1):237-9. PubMed ID: 7350611
[TBL] [Abstract][Full Text] [Related]
2. A strategy for the contrast enhancement of malignant tumors using dynamic computed tomography and intravascular pharmacokinetics.
Young SW; Turner RJ; Castellino RA
Radiology; 1980 Oct; 137(1 Pt 1):137-47. PubMed ID: 7422835
[TBL] [Abstract][Full Text] [Related]
3. Comparison of hepatic VX2-carcinomas after intra-arterial, intraportal and intraparenchymal tumor cell injection. An angiographic and computed tomographic study in the rabbit.
Burgener FA; Violante MR
Invest Radiol; 1979; 14(5):410-4. PubMed ID: 500305
[TBL] [Abstract][Full Text] [Related]
4. Contrast enhancement of focal hepatic lesions in CT: effect of size and histology.
Burgener FA; Hamlin DJ
AJR Am J Roentgenol; 1983 Feb; 140(2):297-301. PubMed ID: 6600347
[TBL] [Abstract][Full Text] [Related]
5. Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography.
Mattrey RF; Long DM; Multer F; Mitten R; Higgins CB
Radiology; 1982 Dec; 145(3):755-8. PubMed ID: 7146408
[TBL] [Abstract][Full Text] [Related]
6. Serine- and mannose-modified liposomal contrast agent for computed tomography: evaluation of the enhancement in rabbit liver VX-2 tumor model.
Okada M; Isoda T; Kumano S; Kagawa Y; Araki T; Onishi H; Hori M; Kim T; Motokui Y; Wada T; Murakami T
Contrast Media Mol Imaging; 2010; 5(3):140-6. PubMed ID: 20586033
[TBL] [Abstract][Full Text] [Related]
7. CT imaging with iopromide liposomes in a rabbit model.
Krause W; Schönborn A; Rupp K
J Liposome Res; 2011 Sep; 21(3):229-36. PubMed ID: 21039317
[TBL] [Abstract][Full Text] [Related]
8. Particulate contrast media for computed tomographic scanning of the liver.
Violante MR; Dean PB; Fischer HW; Mahoney JA
Invest Radiol; 1980; 15(6 Suppl):S171-5. PubMed ID: 7203919
[TBL] [Abstract][Full Text] [Related]
9. A comparison between IEEC, a new biodegradable particulate contrast medium, and iohexol in a tumor model of computed tomography imaging of the liver.
Leander P; Golman K; Strande P; Klaveness J; Besjakov J; Fält K
Invest Radiol; 1993 Jun; 28(6):513-9. PubMed ID: 8320069
[TBL] [Abstract][Full Text] [Related]
10. [Animal experimental studies on the application of dynamic computed tomography to liver tumors].
Claussen C; Weinmann HJ; Schnoy N
Rofo; 1983 Sep; 139(3):266-8. PubMed ID: 6411544
[TBL] [Abstract][Full Text] [Related]
11. 1999 ARRS Executive Council Award. Contrast-enhanced CT of small hypovascular hepatic tumors: effect of lesion enhancement on conspicuity in rabbits. American Roentgen Ray Society.
Kuszyk BS; Bluemke DA; Choti MA; Horton KM; Magee CA; Fishman EK
AJR Am J Roentgenol; 2000 Feb; 174(2):471-5. PubMed ID: 10658727
[TBL] [Abstract][Full Text] [Related]
12. Time-related contrast enhancement of blood, normal muscle, and V2 carcinoma in the rabbit as determined by CT scanning.
Young SW; Rumbaugh CL
Invest Radiol; 1978; 13(4):334-6. PubMed ID: 689827
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography of rabbit V2 carcinoma after intraarterial contrast enhancement.
Young SW; Enzmann D; Marglin SI
J Comput Assist Tomogr; 1979 Apr; 3(2):185-8. PubMed ID: 429626
[TBL] [Abstract][Full Text] [Related]
14. Contrast enhancement dynamic CT measurements and a mathematical model.
Cassel DM; Young SW; Turner R
Invest Radiol; 1982; 17(1):82-9. PubMed ID: 7076440
[No Abstract] [Full Text] [Related]
15. Liver metastases on quantitative color mapping of the arterial enhancement fraction from multiphasic CT scans: evaluation of the hemodynamic features and correlation with the chemotherapy response.
Joo I; Lee JM; Kim KW; Klotz E; Han JK; Choi BI
Eur J Radiol; 2011 Dec; 80(3):e278-83. PubMed ID: 21251785
[TBL] [Abstract][Full Text] [Related]
16. [Modification of the method for preparing rabbit liver VX2 tumor model and its MRI findings].
Quan XY; Xie W; Zhang XL; Sun XJ; Zhu XL; Yan Z; Liang W
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):747-9. PubMed ID: 16793590
[TBL] [Abstract][Full Text] [Related]
17. Improved rabbit brain tumor model amenable to diagnostic radiographic procedures.
Carson BS; Anderson JH; Grossman SA; Hilton J; White CL; Colvin OM; Clark AW; Grochow LB; Kahn A; Murray KJ
Neurosurgery; 1982 Nov; 11(5):603-8. PubMed ID: 7155326
[TBL] [Abstract][Full Text] [Related]
18. [Dynamic evaluation of rabbit VX2 hepatic carcinoma with CT and MRI].
Jia HS; Quan XY; Zeng S; Wen ZB
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):141-4. PubMed ID: 12390810
[TBL] [Abstract][Full Text] [Related]
19. Contrast enhancement of malignant tumors after intravenous polyvinylpyrrolidone with metallic salts as determined by computed tomography.
Young SW; Muller HH; Marincek B
Radiology; 1981 Jan; 138(1):97-105. PubMed ID: 7455104
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted magnetic resonance imaging to evaluate microvascular density after transarterial embolization ablation in a rabbit VX2 liver tumor model.
Qian T; Chen M; Gao F; Meng F; Gao X; Yin H
Magn Reson Imaging; 2014 Oct; 32(8):1052-7. PubMed ID: 24970024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
